Lv62
2750 积分 2023-09-16 加入
Immunotherapy of MSI Cancer: Facts and Hopes
1个月前
已完结
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
1个月前
已完结
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability
1个月前
已完结
Pembrolizumab Versus chemotherapy in microsatellite instability–high or mismatch repair–deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase 3 KEYNOTE-177 study
1个月前
已完结
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
1个月前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
1个月前
已完结
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer
4个月前
已完结
Clinical management of metastatic colorectal cancer in the era of precision medicine
4个月前
已完结
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation
4个月前
已完结
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment
4个月前
已完结
皖公网安备34019202002308
